IDEXX
Global veterinary diagnostics leader with inVue Dx AI cellular analyzer.
About IDEXX
IDEXX is the global leader in veterinary diagnostics, offering in-clinic analyzers, reference laboratories, and AI-powered diagnostic tools. The company's flagship AI product, the inVue Dx Cellular Analyzer, provides slide-free, AI-driven, lab-quality results in 10 minutes. IDEXX also launched the Cancer Dx Panel and ImageVue DR50 Plus imaging system, and placed over 1,900 inVue Dx units in Q4 2025 alone. As a publicly traded company (IDXX) with $4.6-4.7 billion in revenue guidance for 2026, IDEXX has the resources to invest heavily in AI-driven veterinary diagnostics. IDEXX also owns ezyVet, a leading cloud PIMS.
Note: Public company (IDXX); $4.6-4.7B revenue; owns ezyVet
Key Features
- inVue Dx Cellular Analyzer (slide-free, AI-driven)
- Lab-quality results in 10 minutes
- Cancer Dx Panel
- ImageVue DR50 Plus imaging system
- In-clinic and reference lab services
- Global veterinary diagnostics network
Pricing
Enterprise
Target Audience
Veterinary clinics and hospitals worldwide
Category
🧪 Lab Analysis
AI-enhanced diagnostic analyzers and laboratory services for veterinary medicine.
Looking for a Veterinary AI Scribe?
PawfectNotes records your appointments and automatically generates SOAP notes, discharge instructions, and more. Free to get started — no credit card required.